December 22, 2025
The U.S. behavioral health market is projected to expand from USD 101.84 billion in 2026 to USD 159.35 billion...
Read MoreDecember 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreDecember 26, 2025
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 238.65 billi...
Read MoreOctober 07, 2025
According to forecasts, the global 3D bioprinting market will grow from USD 2.58 billion in 2024 to USD 8.42 billion by 2034, with an expected CAGR of 12.54%. The 3D bioprinting market is expanding due to growing demand for organ transplantation as well as rising developments in bioinks. Asia Pacific led the market due to expanding healthcare....
October 07, 2025
According to market projections, the global continuous manufacturing systems market, valued at USD 689.15 million in 2024, is anticipated to reach USD 2148.06 million by 2034, growing at a CAGR of 12.04% over the next decade.The market is growing due to rising demand for cost-effective, efficient, and high-quality production processes. It reduces d...
October 07, 2025
Projections indicate that, the global protein expression technology market will increase from USD 2.85 billion in 2024 to USD 5.58 billion by 2034, experiencing a CAGR of 6.94% over the next 10 years. The protein expression technology market is expanding due to the increasing use of biopharmaceuticals as well as rising advancements in therapeutic a...
October 07, 2025
According to market projections, the AAV gene therapy sector is expected to grow from USD 2.75 billion in 2024 to USD 78.56 billion by 2034, reflecting a CAGR of 40.1%. This AAV gene therapy market growth is driven by emerging trends and strong demand across key sectors. The rising demand for gene therapy and growing genomics research boost the mar...
October 07, 2025
According to forecasts, the Middle East and Africa biotechnology market will grow from USD 46.53 billion in 2024 to USD 125.91 billion by 2034, with an expected CAGR of 10.80%. Rising food security concerns are estimated to drive the growth of the market. South Africa led the global market owing to its advanced research infrastructure in the region...
October 07, 2025
Market insights predict the North America behavioral health industry will increase from USD 109.21 billion in 2024 to USD 193.03 billion by 2034, achieving a CAGR of 5.86%. The rising incidence of substance use and mental disorders, increased health awareness, and improved patient care fuel the need for behavioral health solutions. North America do...
October 07, 2025
Market insights predict, the Europe biotechnology industry is expected to grow from USD 418.76 billion in 2024 to USD 1208.75 billion by 2034, driven by a CAGR of 11.30%. The presence of a robust biotech hub is driving the Europe biotechnology market. Germany led the market due to the increased investment in infrastructure....
October 07, 2025
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expanding due to growing innovations....
October 06, 2025
According to forecasts, the global regenerative medicine market will grow from USD 20.09 billion in 2024 to USD 139.70 billion by 2034, with an expected CAGR of 21.4%. North America leads the regenerative medicine market with a 49.21% share. The wound care segment is the fastest-growing, expected to expand at a 17.3% CAGR from 2023 to 2032. Es...
October 06, 2025
According to market projections, the global medical cannabis market valued at USD 14.34 billion in 2024, is anticipated to reach USD 52.23 billion by 2034, growing at a CAGR of 13.8% over the next decade. Chronic pain management led in 2022, holding 52% of the share. North America dominates with a 56% share, driven by early legalization, a strong m...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com